Table 2.
Univariate (A) and multivariate analysis (B) for correlation of circulating lymphocytes with therapy response in TNBC.
| A | ||
|---|---|---|
| All Cases | Z | P |
| CD3+ | -2.035 | 0.042 |
| Lymphocytes | -1.45 | 0.147 |
| CD8+ | -0.015 | 0.988 |
| CD4+ | -2.919 | 0.004 |
| CD56+ | -1.8 | 0.072 |
| CD19+ | -0.57 | 0.568 |
| CD45+ | -1.954 | 0.051 |
| CD4+/CD8+ Ratio | -2.106 | 0.035 |
| WBC | -0.198 | 0.843 |
| RBC | -0.244 | 0.807 |
| PLT | -0.974 | 0.330 |
| HB | -0.332 | 0.740 |
| Neutrophils | -0.563 | 0.573 |
| Lymphocytes | -0.977 | 0.329 |
| NLR | -0.861 | 0.389 |
| PLR | -1.113 | 0.266 |
| B | ||
| All Cases | P | Odds ratio (95%CI) |
| CD3+ | 0.295 | 1.679 (0.799-4.639) |
| CD4+ | 0.600 | 1.533 (0.311-1.965) |
| CD4+/CD8+ Ratio | 0.059 | 1.873 (0.967-3.782) |
95%CI, 95% confidence interval.
All P values were two-tailed-sided, and statistical significance was set as P < 0.1.
(Mann-Whitney U test and Multivariate logistic regression model).